These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31653892)

  • 1. Genomic Prediction of 16 Complex Disease Risks Including Heart Attack, Diabetes, Breast and Prostate Cancer.
    Lello L; Raben TG; Yong SY; Tellier LCAM; Hsu SDH
    Sci Rep; 2019 Oct; 9(1):15286. PubMed ID: 31653892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers.
    Mars N; Koskela JT; Ripatti P; Kiiskinen TTJ; Havulinna AS; Lindbohm JV; Ahola-Olli A; Kurki M; Karjalainen J; Palta P; ; Neale BM; Daly M; Salomaa V; Palotie A; Widén E; Ripatti S
    Nat Med; 2020 Apr; 26(4):549-557. PubMed ID: 32273609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient Implementation of Penalized Regression for Genetic Risk Prediction.
    Privé F; Aschard H; Blum MGB
    Genetics; 2019 May; 212(1):65-74. PubMed ID: 30808621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
    Mavaddat N; Michailidou K; Dennis J; Lush M; Fachal L; Lee A; Tyrer JP; Chen TH; Wang Q; Bolla MK; Yang X; Adank MA; Ahearn T; Aittomäki K; Allen J; Andrulis IL; Anton-Culver H; Antonenkova NN; Arndt V; Aronson KJ; Auer PL; Auvinen P; Barrdahl M; Beane Freeman LE; Beckmann MW; Behrens S; Benitez J; Bermisheva M; Bernstein L; Blomqvist C; Bogdanova NV; Bojesen SE; Bonanni B; Børresen-Dale AL; Brauch H; Bremer M; Brenner H; Brentnall A; Brock IW; Brooks-Wilson A; Brucker SY; Brüning T; Burwinkel B; Campa D; Carter BD; Castelao JE; Chanock SJ; Chlebowski R; Christiansen H; Clarke CL; Collée JM; Cordina-Duverger E; Cornelissen S; Couch FJ; Cox A; Cross SS; Czene K; Daly MB; Devilee P; Dörk T; Dos-Santos-Silva I; Dumont M; Durcan L; Dwek M; Eccles DM; Ekici AB; Eliassen AH; Ellberg C; Engel C; Eriksson M; Evans DG; Fasching PA; Figueroa J; Fletcher O; Flyger H; Försti A; Fritschi L; Gabrielson M; Gago-Dominguez M; Gapstur SM; García-Sáenz JA; Gaudet MM; Georgoulias V; Giles GG; Gilyazova IR; Glendon G; Goldberg MS; Goldgar DE; González-Neira A; Grenaker Alnæs GI; Grip M; Gronwald J; Grundy A; Guénel P; Haeberle L; Hahnen E; Haiman CA; Håkansson N; Hamann U; Hankinson SE; Harkness EF; Hart SN; He W; Hein A; Heyworth J; Hillemanns P; Hollestelle A; Hooning MJ; Hoover RN; Hopper JL; Howell A; Huang G; Humphreys K; Hunter DJ; Jakimovska M; Jakubowska A; Janni W; John EM; Johnson N; Jones ME; Jukkola-Vuorinen A; Jung A; Kaaks R; Kaczmarek K; Kataja V; Keeman R; Kerin MJ; Khusnutdinova E; Kiiski JI; Knight JA; Ko YD; Kosma VM; Koutros S; Kristensen VN; Krüger U; Kühl T; Lambrechts D; Le Marchand L; Lee E; Lejbkowicz F; Lilyquist J; Lindblom A; Lindström S; Lissowska J; Lo WY; Loibl S; Long J; Lubiński J; Lux MP; MacInnis RJ; Maishman T; Makalic E; Maleva Kostovska I; Mannermaa A; Manoukian S; Margolin S; Martens JWM; Martinez ME; Mavroudis D; McLean C; Meindl A; Menon U; Middha P; Miller N; Moreno F; Mulligan AM; Mulot C; Muñoz-Garzon VM; Neuhausen SL; Nevanlinna H; Neven P; Newman WG; Nielsen SF; Nordestgaard BG; Norman A; Offit K; Olson JE; Olsson H; Orr N; Pankratz VS; Park-Simon TW; Perez JIA; Pérez-Barrios C; Peterlongo P; Peto J; Pinchev M; Plaseska-Karanfilska D; Polley EC; Prentice R; Presneau N; Prokofyeva D; Purrington K; Pylkäs K; Rack B; Radice P; Rau-Murthy R; Rennert G; Rennert HS; Rhenius V; Robson M; Romero A; Ruddy KJ; Ruebner M; Saloustros E; Sandler DP; Sawyer EJ; Schmidt DF; Schmutzler RK; Schneeweiss A; Schoemaker MJ; Schumacher F; Schürmann P; Schwentner L; Scott C; Scott RJ; Seynaeve C; Shah M; Sherman ME; Shrubsole MJ; Shu XO; Slager S; Smeets A; Sohn C; Soucy P; Southey MC; Spinelli JJ; Stegmaier C; Stone J; Swerdlow AJ; Tamimi RM; Tapper WJ; Taylor JA; Terry MB; Thöne K; Tollenaar RAEM; Tomlinson I; Truong T; Tzardi M; Ulmer HU; Untch M; Vachon CM; van Veen EM; Vijai J; Weinberg CR; Wendt C; Whittemore AS; Wildiers H; Willett W; Winqvist R; Wolk A; Yang XR; Yannoukakos D; Zhang Y; Zheng W; Ziogas A; ; ; ; Dunning AM; Thompson DJ; Chenevix-Trench G; Chang-Claude J; Schmidt MK; Hall P; Milne RL; Pharoah PDP; Antoniou AC; Chatterjee N; Kraft P; García-Closas M; Simard J; Easton DF
    Am J Hum Genet; 2019 Jan; 104(1):21-34. PubMed ID: 30554720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Analysis of Multiple Cohort Datasets Deciphers the Utility of Germline Single-Nucleotide Polymorphisms in Prostate Cancer Diagnosis.
    Zhang W; Dong Y; Sartor O; Zhang K
    Cancer Prev Res (Phila); 2021 Jul; 14(7):741-752. PubMed ID: 33866309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
    Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
    Elife; 2023 Mar; 12():. PubMed ID: 36971353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benchmarking multi-ancestry prostate cancer polygenic risk scores in a real-world cohort.
    Shah Y; Kulm S; Nauseef JT; Chen Z; Elemento O; Kensler KH; Sharaf RN
    PLoS Comput Biol; 2024 Apr; 20(4):e1011990. PubMed ID: 38598551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards clinical utility of polygenic risk scores.
    Lambert SA; Abraham G; Inouye M
    Hum Mol Genet; 2019 Nov; 28(R2):R133-R142. PubMed ID: 31363735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly elevated polygenic risk scores are better predictors of myocardial infarction risk early in life than later.
    Isgut M; Sun J; Quyyumi AA; Gibson G
    Genome Med; 2021 Jan; 13(1):13. PubMed ID: 33509272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.
    Mealiffe ME; Stokowski RP; Rhees BK; Prentice RL; Pettinger M; Hinds DA
    J Natl Cancer Inst; 2010 Nov; 102(21):1618-27. PubMed ID: 20956782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of polygenic risk scores for predicting breast and prostate cancer risk.
    Machiela MJ; Chen CY; Chen C; Chanock SJ; Hunter DJ; Kraft P
    Genet Epidemiol; 2011 Sep; 35(6):506-514. PubMed ID: 21618606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polygenic predisposition to breast cancer and the risk of coronary artery disease.
    D'Souza M; Schou M; Skals R; Weeke PE; Lee C; Smedegaard L; Madelaire C; Gerds TA; Poulsen HE; Hansen T; Grarup N; Pedersen O; Stender S; Engstrøm T; Fosbøl E; Nielsen D; Gislason G; Køber L; Torp-Pedersen C; Andersson C
    Int J Cardiol; 2019 Sep; 291():145-151. PubMed ID: 31155334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polygenic prediction of breast cancer: comparison of genetic predictors and implications for risk stratification.
    Läll K; Lepamets M; Palover M; Esko T; Metspalu A; Tõnisson N; Padrik P; Mägi R; Fischer K
    BMC Cancer; 2019 Jun; 19(1):557. PubMed ID: 31182048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of polygenic risk scores to differentiate between type 1 and type 2 diabetes.
    Shoaib M; Ye Q; IglayReger H; Tan MH; Boehnke M; Burant CF; Soleimanpour SA; Gagliano Taliun SA
    Genet Epidemiol; 2023 Jun; 47(4):303-313. PubMed ID: 36821788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in predicted risks in personal genome testing for common complex diseases.
    Kalf RR; Mihaescu R; Kundu S; de Knijff P; Green RC; Janssens AC
    Genet Med; 2014 Jan; 16(1):85-91. PubMed ID: 23807614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reclassification of genetic-based risk predictions as GWAS data accumulate.
    Krier J; Barfield R; Green RC; Kraft P
    Genome Med; 2016 Feb; 8(1):20. PubMed ID: 26884246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic architecture of complex traits and disease risk predictors.
    Yong SY; Raben TG; Lello L; Hsu SDH
    Sci Rep; 2020 Jul; 10(1):12055. PubMed ID: 32694572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer.
    Karunamuni RA; Huynh-Le MP; Fan CC; Thompson W; Eeles RA; Kote-Jarai Z; Muir K; ; Lophatananon A; Tangen CM; Goodman PJ; Thompson IM; Blot WJ; Zheng W; Kibel AS; Drake BF; Cussenot O; Cancel-Tassin G; Menegaux F; Truong T; Park JY; Lin HY; Bensen JT; Fontham ETH; Mohler JL; Taylor JA; Multigner L; Blanchet P; Brureau L; Romana M; Leach RJ; John EM; Fowke J; Bush WS; Aldrich M; Crawford DC; Srivastava S; Cullen JC; Petrovics G; Parent MÉ; Hu JJ; Sanderson M; Mills IG; Andreassen OA; Dale AM; Seibert TM;
    Int J Cancer; 2021 Jan; 148(1):99-105. PubMed ID: 32930425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score method.
    Chen GB; Lee SH; Montgomery GW; Wray NR; Visscher PM; Gearry RB; Lawrance IC; Andrews JM; Bampton P; Mahy G; Bell S; Walsh A; Connor S; Sparrow M; Bowdler LM; Simms LA; Krishnaprasad K; ; Radford-Smith GL; Moser G
    BMC Med Genet; 2017 Aug; 18(1):94. PubMed ID: 28851283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polygenic modeling of genome-wide association studies: an application to prostate and breast cancer.
    Witte JS; Hoffmann TJ
    OMICS; 2011 Jun; 15(6):393-8. PubMed ID: 21348634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.